Your session is about to expire
← Back to Search
Hemodialysis
Nocturnal vs Daily Hemodialysis for Kidney Failure
N/A
Waitlist Available
Research Sponsored by National Center for Research Resources (NCRR)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult patients with chronic renal failure requiring intermittent hemodialysis with a life expectancy of greater than 2 year
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is testing whether nocturnal dialysis (a form of daily dialysis) is effective in hemodialysis patients in St. Louis, with the hope that it can be expanded to help the 220,000 Americans currently on hemodialysis.
Who is the study for?
This trial is for adults with chronic kidney failure who need regular hemodialysis and are expected to live more than 2 years. It's not specified who can't join, but typically those with other serious health issues or a shorter life expectancy might be excluded.Check my eligibility
What is being tested?
The study is testing if doing hemodialysis at night (nocturnal) every day can improve patient outcomes compared to the usual daily hemodialysis schedule. Success will be measured by less need for blood pressure meds, better bone disease management, quality of life scores, and physical function via oxygen uptake.See study design
What are the potential side effects?
While specific side effects aren't listed here, common ones from frequent dialysis may include low blood pressure during treatment, muscle cramps, insomnia on nocturnal schedules, and potential vascular access complications.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
National Center for Research Resources (NCRR)Lead Sponsor
537 Previous Clinical Trials
317,016 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have chronic kidney failure, need dialysis, and am expected to live more than 2 years.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this investigation only accessible to those under eighty-five years of age?
"This medical trial is suitable for those aged 21 to 75. If a patient falls outside of this range, there are 17 trials applicable to individuals under 18 years old as well as 281 studies available for patients over 65."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger